The drug is called Arcalyst and it is a protein inhibitor. Scientists say it appeared to markedly lower the risk of gout flare-ups during the first few months of treatments.
The goal is to reduce uric acid levels.
The drug, also known as Rilonacept, was shown to be effective in preventing acute gout flares in new patients and was said to be safe and well tolerated.
But experts say the drug is very expensive and for some patients insurance will be an issue.